Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
9.07
+0.20 (2.25%)
At close: Oct 12, 2026, 4:00 PM EDT
9.07
0.00 (0.00%)
After-hours: Oct 12, 2026, 4:00 PM EDT
Benitec Biopharma Employees
Benitec Biopharma had 24 employees as of June 30, 2026. The number of employees increased by 5 or 26.32% compared to the previous year. That makes Benitec Biopharma the 37,730th largest employer in the world and 5,379th in the United States.
Employees
24
Change (1Y)
5
Growth (1Y)
26.32%
Revenue / Employee
n/a
Profits / Employee
-$1,897,750
Market Cap
316.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 24 | 5 | 26.32% |
| Jun 30, 2025 | 19 | 3 | 18.75% |
| Jun 30, 2024 | 16 | -2 | -11.11% |
| Jun 30, 2023 | 18 | 0 | - |
| Jun 30, 2022 | 18 | 4 | 28.57% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| EyePoint | 214 |
| Rocket Pharmaceuticals | 202 |
| Cabaletta Bio | 158 |
| Nautilus Biotechnology | 127 |
| Ocugen | 116 |
| Artiva Biotherapeutics | 115 |
| X4 Pharmaceuticals | 45 |
BNTC News
- 7 days ago - Benitec Biopharma says BB-301 pivotal still on track for mid-2027 - TheFly
- 7 days ago - Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study - GlobeNewsWire
- 27 days ago - Benitec Biopharma price target raised to $17 from $16 at Wedbush - TheFly
- 27 days ago - Benitec Biopharma price target raised to $17 from $16 at Wedbush - TheFly
- 27 days ago - Benitec Biopharma files $200M mixed securities shelf - TheFly
- 4 weeks ago - Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update - GlobeNewsWire
- 4 weeks ago - Benitec Biopharma Earnings release: Q4 2026 - Filings
- 4 weeks ago - Benitec Biopharma Annual report: Q4 2026 - Filings